EC Clinical and Medical Case Reports

Research Article Volume 7 Issue 4 - 2024

Haemoglobin Level and its Predictors among Patients with Chronic Kidney Disease on Haemodialysis in Hargeisa Group Hospital, Hargeisa, Somaliland

Abdulkadir Mohamed Nuh1*, Abdeta Muktar Ahmed2 and Tefera Belachew Lema3

1Department of Nutrition and Dietetics, Addis Ababa Medical University College, Hargeisa, Somaliland

2Department of Clinical Nursing and Midwifery, Addis Ababa Medical University College, Hargeisa, Somaliland

3Department of Nutrition and Dietetics, Jimma University, Ethiopia

*Corresponding Author: Abdulkadir Mohamed Nuh, Department of Nutrition and Dietetics, Addis Ababa Medical University College, Hargeisa, Somaliland.
Received: February 24, 2024; Published: April 18, 2024



Background: Chronic kidney disease (CKD) is defined as the presence of irreversible renal damage manifesting with reduction in the glomerular filtration rate. More than 800 million people are affected by chronic kidney diseases worldwide. CKD is more prevalent in older individuals and in people experiencing poorly controlled diabetes mellitus and hypertension. Most people with kidney disease will develop anemia, which happens early and grow worse as kidneys fail and can no longer make erythropoietin (EP). Evidence suggests that haemodialysis could lead to anaemia through the loss of blood, while there are also arguments that haemodialysis prevents anaemia through treating the underlying causes that precipitated it.

Purpose of the Study: This study was to assess haemoglobin level and associated factors among patients with chronic kidney disease on haemodialysis in Hargeisa Group Hospital, Hargeisa and Somaliland to generate evidence for practice.

Methods: An institution-based cross-sectional study was conducted for a period of four weeks from 30 June to 27 July 20222 at Hargeisa Group Hospital, Department of Haemodialysis. Sixty-five patients undergoing haemodialysis were included in the analyses using consecutive sampling technique. Descriptive statistics and multivariable linear regression analyses was done to isolate independent predictors of haemoglobin level after checking assumptions.

Results: Among 65 participants in the study, 67.3% were males and 32.3% were females. The mean (± SD) of age was 51.88 ± 8.91 years. The mean (± SD) haemoglobin level was 8.43 (± 1.30) with the values being 8.61 (1.23) and 8.03 (1.37), for males and females, respectively.

On multivariable linear regression analyses after adjusting for background variables, duration of chronic kidney diseases, age of the patients, having any scheduled physical activities before becoming sick, glomerular filtration rate and number of meals prepared from meat or meat products per week were significantly associated with hemoglobin level (P < 0.05). For one year increase in the duration of the chronic kidney diseases, hemoglobin level decreased by 0.01 (ß = -0.01, P = 0.004). Likewise, for one year increase in the age of the patient, hemoglobin decreased by 0.036 (ß = -0.0, P = 36, 0.038).

Conversely, having any scheduled physical activities before becoming sick increased hemoglobin level by 0.923 (ß = 0.923, P = 0.003), while a unit increase in the glomerular filtration rate increased hemoglobin level by 0.132 (ß = 0.132, P = 0.018). Likewise, an increase in the number of meals prepared from meat or meat products per week increased hemoglobin level by 0.444 (ß = 0.444, P = 0.045).

Conclusion: The results showed that haemoglobin level is low among patients on haemodialysis, which needs to considered in the treatment plan. The findings imply the need for treatment of anaemia as well as dietary and lifestyle modifications including encouraging physical activity specially for patients with longer diseases duration.

 Keywords: Demography; CKD; Haemodialysis; Clinical Profile

  1. Levey AS., et al. “Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving global outcomes (KDIGO)”. Kidney International6 (2005): 2089-2100.
  2. Coresh J., et al. “Prevalence of chronic kidney disease in the United States”. Journal of the American Medical Association 17 (2007): 2038-2047.
  3. Barros E., et al. “Nefrologia: rotinas, diagnóstico e tratamento”. 3rd Porto Alegre: Artmed (2006).
  4. Csaba P Kovesdy. “Epidemiology of chronic kidney diseases: an update 2022”. Kidney International Journal Supplements1 (2022): 7-11.
  5. Hariparshad S., et al. “The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally”. BMC Nephrology 24 (2023): 62.
  6. George C., et al. “The chronic kidney disease in Africa (CKD-Africa) collaboration: lessons from a new pan-African network”. BMJ Global Health8 (2021): e006454.
  7. Naicker S. “End-stage renal disease in Sub-Saharan Africa”. Kidney International Supplements2 (2013): 161-163.
  8. Akinsola W., et al. “Diseases causing chronic renal failure in Nigerians--a prospective study of 100 cases”. African Journal of Medicine and Medical Sciences2 (1989): 131-137.
  9. Muiru AN., et al. “The epidemiology of chronic kidney disease (CKD) in rural East Africa: a population-based study”. PLoS One3 (2020): e0229649.
  10. Central Statistics Department, Ministry of Planning and National Development, Somaliland Government. The Somaliland Health and Demographic Survey 2020.
  11. Atkinson MA and Warady BA. “Anemia in chronic kidney disease”. Pediatric Nephrology2 (2018): 227-238.
  12. Taderegew MM., et al. “Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis”. PLoS One2 (2023): e0280817.
  13. Bowry SK and Gatti E. “Impact of hemodialysis therapy on anemia of chronic kidney disease: the potential mechanisms”. Blood Purification 3 (2011): 210-219.
  14. Stefanova D., et al. “Hepcidin protects against lethal Escherichia coli sepsis in mice inoculated with isolates from septic patients”. Infection and Immunity 7 (2018): e00253.
  15. Winterbourn CC. “Toxicity of iron and hydrogen peroxide: the Fenton reaction”. Toxicology Letters 82-83 (1995): 969-974.
  16. Nooh F Ali., et al. “Prevalence and risk factors of hypertension in Hargeisa, Somaliland: A hospital-based cross-sectional study”. Diseases2 (2023): 62.
  17. Raosoft for sample size calculator.
  18. De Onis M and Habicht JP. “Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee”. The American Journal of Clinical Nutrition4 (1996): 650-658.
  19. Shen Y., et al. “Anemia among Chinese patients with chronic kidney disease and its association with quality of life-results from the Chinese cohort study of chronic kidney disease (C-STRIDE)”. BMC Nephrology1 (2021): 64.
  20. Iseki K and Kohagura K. “Anemia as a risk factor for chronic kidney disease”. Kidney International 107 (2007): S4-S9.
  21. Kovesdy CP., et al. “Epidemiology of dietary nutrient intake in ESRD”. Seminars in Dialysis4 (2010): 353-358.
  22. Shaikh H., et al. “Anemia of chronic renal disease” (2023).
  23. Erslev AJ. “Anemia of chronic renal disease”. Archives of Internal Medicine5 (1970): 774-780.
  24. Mikhail A., et al. “Renal association clinical practice guideline on anaemia of chronic kidney disease”. BMC Nephrology1 (2017): 1-29.
  25. Hanna RM., et al. “Burden of anemia in chronic kidney disease: beyond erythropoietin”. Advances in Therapy1 (2021): 52-75.
  26. Costacurta M., et al. “The impact of chronic kidney disease on nutritional status and its possible relation with oral diseases”. Nutrients 10 (2022): 2002.

Abdulkadir Mohamed Nuh., et al. "Haemoglobin Level and its Predictors among Patients with Chronic Kidney Disease on Haemodialysis in Hargeisa Group Hospital, Hargeisa, Somaliland." EC Clinical and Medical Case Reports   7.4 (2024): 01-10.